Recent Quotes (30 days)

You have no recent quotes
chg | %

Solarvest Bioenergy Inc  

(Public, CVE:SVS)   Watch this stock  
Find more results for SVS
0.000 (0.00%)
Feb 8 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.15 - 0.28
Open     -
Vol / Avg. 0.00/2,323.00
Mkt cap 4.94M
P/E     -
Div/yield     -
EPS -0.08
Shares 21.48M
Beta 0.66
Inst. own     -

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -115.46% -122.62%
Return on average equity - -592.64%
CDP Score - -


439 Helmcken St
+1-604-6843323 (Phone)
+1-604-6843350 (Fax)

Website links


Solarvest BioEnergy Inc. is a Canada-based algae technology company. The Company is engaged in the research and development of natural and genetically modified microalgae strains. The Company has algae-based biological technologies directed to develop and commercialize nutraceuticals and clean energy. The company operates two research operations, one in Summerville, PEI developing media formulations and solvent free extraction processes and one in Bloomington, Indiana focusing on genetic enhancements for clean energy. The company produces Omega-III Fatty Acid Products such as algae flour, algae oil, pharmaceutical grade oil and bio-hydrogen. It produces high amounts of therapeutic proteins from algae using its technology to produce Bone Morphogenetic Protein (BMP), is applied during orthopedic surgery to fractures to accelerate bone growth and speed recovery. The Company’s subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc.

Officers and directors

Kenneth A. Cawkell Chairman of the Board, Secretary
Age: 64
Gerri J. Greenham President, Chief Executive Officer, Director
Joseph Heng Chief Financial Officer
William M. Cheliak Independent Director
Mark S. Ledwell Independent Director
Michael L. O'Brien Independent Director